CSI Market
Sign In | Register

Prelude Therapeutics Inc (PRLD) Annual Balance Sheets

Annual · GAAP · USD millions
Access PRLD quarterly Balance Sheets →
This page allows investors to track Prelude Therapeutics Inc's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent35.26
Marketable Securities, Current SH67.96
Cash & Short-term Investments102.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current2.48
Total Current Assets105.69
Equipment/Property/Plant Net5.11
Other Assets, Noncurrent30.51
Restricted Cash3.24
Operating Lease Right Of Use Asset27.17
Total Assets141.32
Liabilities
Accounts Payable, Current AC3.98
Accrued Liabilities, Current AC12.53
Other Liabilities, Current0.00
Deferred Revenue, Current DE33.73
Total Current Liabilities52.99
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE1.80
Other liabilities, Noncurrent17.89
Operating Lease Liability Current2.74
Total Liabilities72.68
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock751.68
Retained Earnings / Accumulated Deficit-683.06
Other Equity0.01
Common Stockholder's Equity68.64
Total Stockholder's Equity68.64
Liabilities & Stockholder's Equity141.32
4 historic quarters locked

Sign in to unlock the full Prelude Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Prelude Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-099428

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.